151 related articles for article (PubMed ID: 2578287)
1. Does ultrasound examination render biochemical tests obsolete in the prediction of early pregnancy failure?
Westergaard JG; Teisner B; Sinosich MJ; Madsen LT; Grudzinskas JG
Br J Obstet Gynaecol; 1985 Jan; 92(1):77-83. PubMed ID: 2578287
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of biochemical tests in the assessment of fetal outcome in threatened abortion.
Salem HT; Ghaneimah SA; Shaaban MM; Chard T
Br J Obstet Gynaecol; 1984 Apr; 91(4):382-5. PubMed ID: 6608956
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound and circulating placental protein measurements in complications of early pregnancy.
Stabile I; Campbell S; Grudzinskas JG
Br J Obstet Gynaecol; 1989 Oct; 96(10):1182-91. PubMed ID: 2480155
[TBL] [Abstract][Full Text] [Related]
4. HCG, HPL, oestradiol, progesterone and AFP in serum in patients with threatened abortion.
Kunz J; Keller PJ
Br J Obstet Gynaecol; 1976 Aug; 83(8):640-4. PubMed ID: 60125
[TBL] [Abstract][Full Text] [Related]
5. Value of Schwangerschaftsprotein 1 (SP1) and pregnancy-associated plasma protein-A (PAPP-A) in the clinical management of threatened abortion.
Masson GM; Anthony F; Wilson MS
Br J Obstet Gynaecol; 1983 Feb; 90(2):146-9. PubMed ID: 6186269
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy-associated plasma protein A in the prediction of early pregnancy failure.
Westergaard JG; Sinosich MJ; Bugge M; Madsen LT; Teisner B; Grudzinskas JG
Am J Obstet Gynecol; 1983 Jan; 145(1):67-9. PubMed ID: 6184995
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum and urine hCG levels with SP1 and PAPP-A levels in patients with first-trimester vaginal bleeding.
Masson GM; Anthony F; Wilson MS; Lindsay K
Obstet Gynecol; 1983 Feb; 61(2):223-6. PubMed ID: 6185893
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of postimplantation embryo viability following successful in vitro fertilization and embryo transfer by measurement of placental proteins.
Sinosich MJ; Ferrier A; Saunders DM
Fertil Steril; 1985 Jul; 44(1):70-4. PubMed ID: 2408927
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein: a marker for threatened abortion.
Sande HA; Fagerhol M; Molnar O; Foss OP; Torjesen P
Int J Gynaecol Obstet; 1978-1979; 16(4):293-5. PubMed ID: 86467
[TBL] [Abstract][Full Text] [Related]
10. Can pregnancy-associated plasma protein A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and confirmed fetal viability?
Ruge S; Pedersen JF; Sørensen S; Lange AP
Acta Obstet Gynecol Scand; 1990; 69(7-8):589-95. PubMed ID: 1709769
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of hormone determinations in the first half of pregnancy.
Gerhard I; Runnebaum B
Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):1-17. PubMed ID: 6203784
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of postimplantation embryo viability by measurement of PAPP-A, SP1, and hCG.
Sinosich MJ; Ferrier A; Saunders DM
Ann N Y Acad Sci; 1985; 442():440-4. PubMed ID: 2409861
[TBL] [Abstract][Full Text] [Related]
13. Measurements of placental, decidual, and fetal proteins before and after chorionic villus sampling.
Stabile I; Warren R; Rodeck C; Grudzinskas JG
Prenat Diagn; 1988 Jun; 8(5):387-91. PubMed ID: 2457210
[TBL] [Abstract][Full Text] [Related]
14. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
Hertz JB; Schultz-Larsen P
Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
[TBL] [Abstract][Full Text] [Related]
15. The concentrations of SP1 beta and SP1 alpha in retroplacental and peripheral blood at term.
Ahmed AG; Klopper A
Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):77-81. PubMed ID: 6196240
[TBL] [Abstract][Full Text] [Related]
16. Prediction of fetal alcohol syndrome by maternal alpha fetoprotein, human placental lactogen and pregnancy specific beta 1-glycoprotein.
Halmesmäki E; Autti I; Granström ML; Heikinheimo M; Raivio KO; Ylikorkala O
Alcohol Alcohol Suppl; 1987; 1():473-6. PubMed ID: 2447904
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy-specific and pregnancy-associated proteins in threatened abortion.
Bersinger NA; Keller PJ; Naiem A; Fischer M; Schneider H
Gynecol Endocrinol; 1987 Dec; 1(4):379-84. PubMed ID: 2459901
[TBL] [Abstract][Full Text] [Related]
18. The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific beta 1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma.
Szymendera JJ; Kaminska JA; Nowacki MP; Szawłowski AW; Gadek A
Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1047-52. PubMed ID: 6173222
[No Abstract] [Full Text] [Related]
19. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study.
Dutton PJ; Warrander LK; Roberts SA; Bernatavicius G; Byrd LM; Gaze D; Kroll J; Jones RL; Sibley CP; Frøen JF; Heazell AE
PLoS One; 2012; 7(7):e39784. PubMed ID: 22808059
[TBL] [Abstract][Full Text] [Related]
20. Placental protein and hormone measurements in twin pregnancy.
Westergaard JG; Teisner B; Hau J; Grudzinskas JG
Br J Obstet Gynaecol; 1985 Jan; 92(1):72-6. PubMed ID: 2578286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
